NCT04222569

Brief Summary

Assessment and comparison of three spontaneous breathing trials in five specific profiles of intensive care unit and perioperative patients. A physiological cross over study

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
117

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jun 2020

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 9, 2019

Completed
1 month until next milestone

First Posted

Study publicly available on registry

January 10, 2020

Completed
5 months until next milestone

Study Start

First participant enrolled

June 15, 2020

Completed
3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 15, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 15, 2023

Completed
Last Updated

August 25, 2023

Status Verified

August 1, 2023

Enrollment Period

3 years

First QC Date

December 9, 2019

Last Update Submit

August 23, 2023

Conditions

Keywords

Intensive Care UnitCritical CareMechanical Ventilation WeaningSpontaneous Breath TrialRehabilitation

Outcome Measures

Primary Outcomes (1)

  • Esophageal Pressure Time Product per minute (PTPes.min)

    In cmH2O.s/min. Assessment of patient's inspiratory effort. Integration of esophageal swing pressure over time, performed with a second-generation balloon esophageal catheter, immediately before and after each spontaneous breathing trial, before and 20 min after extubation

    Day one

Secondary Outcomes (2)

  • Esophageal Pressure Time Product per minute (PTPes.min)

    Day two

  • Esophageal Pressure Time Product per minute (PTPes.min)

    Day three

Other Outcomes (8)

  • Tidal impedance variation (TIV) assessed with Electrical Impedance Tomography

    Day one

  • End Expiratory Lung Impedance (EELZ) assessed with Electrical Impedance Tomography

    Day one

  • Global inhomogeneity index (GI) assessed with Electrical Impedance Tomography

    Day one

  • +5 more other outcomes

Study Arms (6)

T-piece and PSV 7 PEEP 0 and PSV 0 PEEP 0

EXPERIMENTAL

First T-piece trial for 15 min. After 10 min of rest, PSV 7 cmH2O and PEEP 0 cmH2O trial for 15 min. After 10 min of rest, PSV 0 cmH2O and PEEP 0 cmH2O trial for 15 min.

Procedure: T-pieceProcedure: PSV 7 and PEEP 0Procedure: PSV 0 and PEEP 0

T-piece and PSV 0 PEEP 0 and PSV 7 PEEP 0

EXPERIMENTAL

First T-piece trial for 15 min. After 10 min of rest, PSV 0 cmH2O and PEEP 0 cmH2O trial for 15 min. After 10 min of rest, PSV 7 cmH2O and PEEP 0 cmH2O trial for 15 min.

Procedure: T-pieceProcedure: PSV 7 and PEEP 0Procedure: PSV 0 and PEEP 0

PSV 0 PEEP 0 and PSV 7 PEEP 0 and T-piece

EXPERIMENTAL

First PSV 0 cmH2O and PEEP 0 cmH2O trial for 15 min. After 10 min of rest, PSV 7 cmH2O and PEEP 0 cmH2O trial for 15 min. After 10 min of rest, T-piece trial for 15 min.

Procedure: T-pieceProcedure: PSV 7 and PEEP 0Procedure: PSV 0 and PEEP 0

PSV 0 PEEP 0 and T-piece and PSV 7 PEEP 0

EXPERIMENTAL

First PSV 0 cmH2O and PEEP 0 cmH2O trial for 15 min. After 10 min of rest, T-piece trial for 15 min. After 10 min of rest, PSV 7 cmH2O and PEEP 0 cmH2O trial for 15 min.

Procedure: T-pieceProcedure: PSV 7 and PEEP 0Procedure: PSV 0 and PEEP 0

PSV 7 PEEP 0 and T-piece and PSV 0 PEEP 0

EXPERIMENTAL

First PSV 7 cmH2O and PEEP 0 cmH2O trial for 15 min. After 10 min of rest, T-piece trial for 15 min. After 10 min of rest, PSV 0 cmH2O and PEEP 0 cmH2O trial for 15 min.

Procedure: T-pieceProcedure: PSV 7 and PEEP 0Procedure: PSV 0 and PEEP 0

PSV 7 PEEP 0 and PSV 0 PEEP 0 and T-piece

EXPERIMENTAL

First PSV 7 cmH2O and PEEP 0 cmH2O trial for 15 min. After 10 min of rest, PSV 0 cmH2O and PEEP 0 cmH2O trial for 15 min. After 10 min of rest, T-piece trial for 15 min.

Procedure: T-pieceProcedure: PSV 7 and PEEP 0Procedure: PSV 0 and PEEP 0

Interventions

T-piecePROCEDURE

Spontaneous breath trial with a T-piece

PSV 0 PEEP 0 and PSV 7 PEEP 0 and T-piecePSV 0 PEEP 0 and T-piece and PSV 7 PEEP 0PSV 7 PEEP 0 and PSV 0 PEEP 0 and T-piecePSV 7 PEEP 0 and T-piece and PSV 0 PEEP 0T-piece and PSV 0 PEEP 0 and PSV 7 PEEP 0T-piece and PSV 7 PEEP 0 and PSV 0 PEEP 0

Spontaneous breath trial with a pressure support ventilation of 7 cmH2O and no positive end expiratory pressure

PSV 0 PEEP 0 and PSV 7 PEEP 0 and T-piecePSV 0 PEEP 0 and T-piece and PSV 7 PEEP 0PSV 7 PEEP 0 and PSV 0 PEEP 0 and T-piecePSV 7 PEEP 0 and T-piece and PSV 0 PEEP 0T-piece and PSV 0 PEEP 0 and PSV 7 PEEP 0T-piece and PSV 7 PEEP 0 and PSV 0 PEEP 0

Spontaneous breath trial without pressure support ventilation and positive end expiratory pressure, with a patient intubated and connected to the ventilator

PSV 0 PEEP 0 and PSV 7 PEEP 0 and T-piecePSV 0 PEEP 0 and T-piece and PSV 7 PEEP 0PSV 7 PEEP 0 and PSV 0 PEEP 0 and T-piecePSV 7 PEEP 0 and T-piece and PSV 0 PEEP 0T-piece and PSV 0 PEEP 0 and PSV 7 PEEP 0T-piece and PSV 7 PEEP 0 and PSV 0 PEEP 0

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • ICU patient with invasive mechanical ventilation for at least 24 hours
  • Physician decision to extubate and all criteria for ventilatory weaning must be present
  • Resolution of disease acute phase for which the patient was intubated
  • Conscious patient (Richmond Agitation-Sedation Scale (RASS) \> 0), no sedation
  • Good coughing effort, good swallowing, positive leak test (\> 12% of tidal volume (VT))
  • No important secretions
  • No respiratory acidosis, adequate oxygenation (PaO2 / FiO2 \> 150 mmHg and CPAP ≤ 8)
  • Adequate pulmonary function (respiratory rate (RR) ≤ 35, negative inspiratory force (NIF) \> 20 cmH2O, RR/VT \< 105)
  • Stable cardiovascular status (heart rate (HR) \< 140 bpm, systolic blood pressure \> 90 mmHg, no or minimal vasopressors)
  • If severe brain injury, the VISAGE score must be ≥ 3 (visual pursuit, good swallowing, GCS \> 10)

You may not qualify if:

  • Obese patients with BMI ≥ 35 kg/m2
  • Contraindication for nasogastric tube or esophageal manometric balloon placement
  • Refusal of study participation or to pursue the study by the patient, no consent
  • Pregnancy or breastfeeding
  • Absence of coverage by the French statutory healthcare insurance system

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Centre Hospitalier Universitaire Saint Eloi

Montpellier, Herault, 34000, France

Location

Related Publications (2)

  • Mahul M, Jung B, Galia F, Molinari N, de Jong A, Coisel Y, Vaschetto R, Matecki S, Chanques G, Brochard L, Jaber S. Spontaneous breathing trial and post-extubation work of breathing in morbidly obese critically ill patients. Crit Care. 2016 Oct 27;20(1):346. doi: 10.1186/s13054-016-1457-4.

    PMID: 27784322BACKGROUND
  • Capdevila M, De Jong A, Aarab Y, Vonarb A, Carr J, Molinari N, Capdevila X, Brochard L, Jaber S. Which spontaneous breathing trial to predict effort to breathe after extubation according to five critical illnesses: the cross-over GLOBAL WEAN study protocol. BMJ Open. 2023 Jul 12;13(7):e070931. doi: 10.1136/bmjopen-2022-070931.

Study Officials

  • Samir Jaber, MD, PHD

    Montpellier University Hospital

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
CROSSOVER
Model Details: Each patient, serving as their own control, realize three SBT for 15 minutes: T-piece, PSV 7 cmH2O without PEEP and PSV 0 cmH2O without PEEP. The order is randomized. The randomization is stratified on pathology. For avoid a carry-over effect, a wash-out period of baseline ventilation for 10 minutes will be respected between trials. The humidification device is a heated humidifier, linked to the ventilator. Data are recorded before (guarantee of real return to baseline) and after each SBT. Then, extubation is decided by clinician in charge, in accordance with guidelines. A 30 min of resting period is respected before. Data are recorded before and 20 minutes after extubation.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 9, 2019

First Posted

January 10, 2020

Study Start

June 15, 2020

Primary Completion

June 15, 2023

Study Completion

June 15, 2023

Last Updated

August 25, 2023

Record last verified: 2023-08

Data Sharing

IPD Sharing
Will share

Individual patient data will be made available upon a reasonable request

Shared Documents
STUDY PROTOCOL
Time Frame
12 months after the main publication
Access Criteria
Data are provided to qualified investigators free of charge. Required documents to request data include a summary of the research plan, request form, and institutional review board (IRB) review. Dataset will be shared after careful examination by the study board of investigators.

Locations